Pre-implantation genetic diagnosis.

Area of Science:

• Reproductive Medicine
• Genetics
• Embryology

Background:

• Genetic disorders are a significant cause of miscarriage and fetal death.
• Pre-implantation genetic diagnosis (PGD) aids in preventing genetic conditions by analyzing embryos created via in vitro fertilization (IVF).
• Traditional PGD methods (FISH, PCR) are highly specialized and sensitive, presenting technical challenges.

Purpose of the Study:

• To review advancements in PGD techniques for diagnosing genetic defects in embryos.
• To highlight newer methods capable of rapidly identifying multiple genetic abnormalities, including aneuploidy, sex, and single-gene defects.
• To discuss the potential for DNA fingerprinting to prevent embryonic cell contamination.

Main Methods:

• Review of current and emerging PGD technologies.
• Analysis of genetic analysis techniques like Fluorescence In Situ Hybridization (FISH) and Polymerase Chain Reaction (PCR).
• Discussion of DNA fingerprinting for quality control in embryonic cell analysis.

Main Results:

• Newer PGD techniques offer rapid diagnosis of multiple genetic defects, including chromosomal aneuploidy and single-gene disorders.
• Embryonic DNA fingerprinting can ensure accuracy by detecting contamination.
• Embryo screening is shown to improve IVF success rates and lower miscarriage rates.

Conclusions:

• Advanced, cost-effective PGD techniques are improving IVF outcomes.
• The improved efficacy and accessibility of PGD suggest its wider application in routine IVF, extending beyond high-genetic-risk patients.
• Future developments may enable PGD for all individuals undergoing IVF, regardless of their genetic risk profile.